Q4 2025 Earnings Call February 10, 2026 8:30 AM ESTCompany ParticipantsMark Grant - Senior VP of Investor Relations ...
Tier Biotech Investor to Advance Preclinical Programs and Extend Cash Runway Progressed Pipeline with New Preclinical Data ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results